The logo of the British pharmaceutical company AstraZeneca is seen at the company’s China Commercial Innovation Centre (CCIC) in Wuxi, Jiangsu province, China, September 15, 2018. Picture taken September 15, 2018. REUTERS/Adam Jourdan
The logo of the British pharmaceutical company AstraZeneca is seen at the company’s China Commercial Innovation Centre (CCIC) in Wuxi, Jiangsu province, China, September 15, 2018. Picture taken September 15, 2018. REUTERS/Adam Jourdan